A prospective trial to evaluate the pharmacokinetics of Adalimumab in patients with Crohn's disease maintenance therapy
Latest Information Update: 26 Feb 2016
At a glance
- Drugs Adalimumab (Primary)
- Indications Crohn's disease
- Focus Pharmacokinetics
Most Recent Events
- 26 Feb 2016 New trial record